According to Zacks, “Brenntag AG engages in the production and distribution of chemicals. It operates through the North America, Latin America, EMEA and Asia Pacific segments. Brenntag AG is headquartered in Mülheim an der Ruhr, Germany. “
Separately, ValuEngine upgraded shares of ZEALAND PHARMA/S from a sell rating to a hold rating in a report on Friday, March 15th.
Shares of OTCMKTS BNTGY opened at $9.51 on Tuesday. The business’s 50 day moving average price is $9.64. The firm has a market cap of $7.38 billion, a P/E ratio of 13.59, a P/E/G ratio of 1.56 and a beta of 1.27. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.76 and a quick ratio of 1.21. BRENNTAG AG/ADR has a 1 year low of $8.20 and a 1 year high of $12.86.
BRENNTAG AG/ADR (OTCMKTS:BNTGY) last announced its quarterly earnings results on Thursday, May 9th. The company reported $0.16 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.16. The business had revenue of $3.70 billion during the quarter. BRENNTAG AG/ADR had a net margin of 3.61% and a return on equity of 14.00%. As a group, equities research analysts forecast that BRENNTAG AG/ADR will post 0.68 earnings per share for the current fiscal year.
The business also recently announced an annual dividend, which was paid on Wednesday, July 3rd. Investors of record on Monday, June 17th were issued a $0.175 dividend. The ex-dividend date was Friday, June 14th. This represents a yield of 1.6%. BRENNTAG AG/ADR’s dividend payout ratio (DPR) is presently 24.29%.
About BRENNTAG AG/ADR
Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.
Recommended Story: What is a short straddle?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for BRENNTAG AG/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BRENNTAG AG/ADR and related companies with MarketBeat.com's FREE daily email newsletter.